Tesla Will Further Dominate EV Market In 2023, Says Analyst — Why He Is Slashing Price Target By 24%
Tesla Inc.’s (NASDAQ: TSLA) stock price received another price target cut, underlining tempered expectations concerning the stoc
‘Sell The Darlings, Own The Dogs’: Why It May Soon Be Time To Buy Tesla, Meta And Other Worst-Performing Stocks Of 2022
Several popular seasonal trading strategies are associated with the closing weeks and opening weeks of the calendar year.
BIT Mining Analyst On Sidelines Until Resurgence In Bitcoin, Clarity On North American Operating Track Record
H.C. Wainwright analyst Kevin Dede maintained a Hold rating on BIT Mining Limited (NYSE: BTCM).
ImmunoGen’s Newly Approved Ovarian Cancer Drug Listed As Preferred Regime
The National Comprehensive Cancer Network (NCCN) released new guidelines for ovarian cancer treatment, which include ImmunoGen Inc's (NASDAQ: IMGN) Elahere (mirvetuximab soravtansine-gynx) as a preferred regimen.
‘It’s Only Getting Worse’ For Carvana, Analyst Says
Wedbush analyst Kevin Merritt reiterated an Underperform rating on the shares of Carvana Co (NYSE:CVNA) with a price target of $1.00. Following…
Elys Likely To Gain From Small Venue Gaming, Land-Based License Additions With FIFA World Cup An Additional Driver: Analyst
H.C. Wainwright analyst Scott Buck reiterated a Buy rating on Elys Game Technology, Corp (NASDAQ:ELYS) with a price target of $2.00. On…
Nio’s Guidance Cut Might Dampen Stock Performance, Analyst Says
Morgan Stanley analyst Tim Hsiao reiterated an Overweight rating on the shares of Nio Inc (NYSE:NIO) with a price target of $16.10.…
Tesla And Apple Could Spark A Santa Claus Rally: Analyst
December is historically one of the best months of the year for the SPDR S&P 500 ETF Trust (NYSE: SPY). However, most of those historical gains have come in the second half of the month in a seasonal trade known as the Santa Claus Rally.
This Analyst Remains Bullish On IMAX As ‘Avatar: The Way of Water’ Continued To Dominate
Rosenblatt Securities analyst Steve Frankel reiterated a Buy rating on the shares of IMAX Corp (NYSE: IMAX) with a price target of $22.00.
3M’s Litigation Concerning Defective Earplug Injuries To US Veterans Mark Another Tough Loss Amid Multiple Lawsuits: Analyst
Mizuho analyst Brett Linzey maintained a Hold rating on 3M Company (NYSE: MMM) with a price target of $130.00.